Complicated pain management in a CYP450 2D6 poor metabolizer.

Opioid metabolism. Mayo Clin Proc (2009) 1.76

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharmacol (2010) 1.15

Voriconazole drastically increases exposure to oral oxycodone. Eur J Clin Pharmacol (2008) 0.98

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study. Eur J Clin Pharmacol (2011) 0.96

Role of active metabolites in the use of opioids. Eur J Clin Pharmacol (2008) 0.91

CYP2D6 genotype dependent oxycodone metabolism in postoperative patients. PLoS One (2013) 0.86

Promethazine misuse among methadone maintenance patients and community-based injection drug users. J Addict Med (2013) 0.80

The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review. Pain Ther (2017) 0.78

Update on prescription extended-release opioids and appropriate patient selection. J Multidiscip Healthc (2013) 0.77

Pharmacology of nonsteroidal antiinflammatory drugs and opioids. Semin Intervent Radiol (2010) 0.77

Regarding CYP450 2D6 poor metabolizers. Pain Pract (2008) 0.77

Toward a systematic approach to opioid rotation. J Pain Res (2014) 0.77

Where Failure Is Not an Option -Personalized Medicine in Astronauts. PLoS One (2015) 0.75

Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists. P T (2010) 0.75

The pharmacogenomics of pain management: prospects for personalized medicine. J Pain Res (2016) 0.75

Genetic control of seed shattering in rice by the APETALA2 transcription factor shattering abortion1. Plant Cell (2012) 1.56

Genetic control of a transition from black to straw-white seed hull in rice domestication. Plant Physiol (2011) 1.22

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists. Org Biomol Chem (2003) 1.08

Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res (2005) 1.04

Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4. Chembiochem (2008) 1.04

An-1 encodes a basic helix-loop-helix protein that regulates awn development, grain size, and grain number in rice. Plant Cell (2013) 1.04

Collection and comparative analysis of 1888 full-length cDNAs from wild rice Oryza rufipogon Griff. W1943. DNA Res (2008) 1.01

Heat shock response in CHO mammalian cells is controlled by a nonlinear stochastic process. PLoS Comput Biol (2007) 0.95

Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett (2005) 0.95

Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. J Mol Biol (2005) 0.91

Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives. Org Biomol Chem (2003) 0.90

Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds. J Med Chem (2005) 0.87

Minimally invasive induction of an early lumbar disc degeneration model in rhesus monkeys. Spine (Phila Pa 1976) (2013) 0.86

Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists. Org Biomol Chem (2007) 0.85

Physical association of GPR54 C-terminal with protein phosphatase 2A. Biochem Biophys Res Commun (2008) 0.84

Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors. Hum Pathol (2008) 0.82

Organic ultraviolet photodetector based on phosphorescent material. Opt Lett (2013) 0.81

Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds. Org Biomol Chem (2005) 0.80

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs. Org Biomol Chem (2006) 0.80

Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. J Med Chem (2005) 0.79

Absolute brightness of fluorescent microspheres. Lab Chip (2008) 0.79

Expression of CXCR4, a G-protein-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists. Methods Enzymol (2009) 0.79

Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians. Neuropsychiatr Dis Treat (2007) 0.77

Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab. Cancer Biol Ther (2013) 0.76

Interfacial self-assembly driven formation of hierarchically structured nanocrystals with photocatalytic activity. ACS Nano (2014) 0.76

Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides. Org Biomol Chem (2004) 0.75

Stereoselective synthesis of 3,6-disubstituted-3,6-dihydropyridin-2-ones as potential diketopiperazine mimetics using organocopper-mediated anti-SN2' reactions and their use in the preparation of low-molecule CXCR4 antagonists. J Org Chem (2006) 0.75

Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy. Adv Exp Med Biol (2009) 0.75

Dispersion and shear-induced orientation of anisotropic nanoparticle filled polymer nanocomposites: insights from molecular dynamics simulation. Nanotechnology (2016) 0.75

Primary central nervous system Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases. Brain Tumor Pathol (2014) 0.75